SUMMARY The effects of alcohol withdrawal on platelet count and platelet function was studied sequentially in a group of alcoholics. Baseline values for platelet count, platelet adenine nucleotides and plasma beta-thromboglobulin (,fTG) level were within the normal range but platelet aggregability (especially with ADP and adrenaline) and circulating platelet aggregates were decreased for the group as a whole.
nucleotides and plasma beta-thromboglobulin (,fTG) level were within the normal range but platelet aggregability (especially with ADP and adrenaline) and circulating platelet aggregates were decreased for the group as a whole.
After alcohol withdrawal there was a pronounced increase in all parameters measured which reached statistical significance in many cases and persisted for two to four weeks.
The potential implications and possible mechanisms for these changes are discussed.
Excess alcohol consumption is associated with an increased risk of cerebrovascular stroke' 2 and thromboembolic disease.3 Alcohol induced hypertension45 is one possible cause of these disorders, although abnormal platelet function might also be a factor in their pathogenesis. While thrombocytopenia and decreased platelet function during alcohol ingestion is documented,6 little information is available concerning platelet function in alcoholics during and after alcohol withdrawal. As intermittent heavy drinking is a common pattern of alcohol abuse, we have investigated platelet function in a group of alcoholics on the day of admission to a treatment unit, and sequentially during four weeks of supervised abstinence.
Patients and methods
The subjects studied were selected from those whose drinking problem led to admission to hospital for "drying out" and psychotherapy. All had been drinking excessively up to the day of admission and had measurable blood alcohol concentrations (20-160 mg/100 ml) Controls were normal hospital personnel with the same sex ratio and covering a similar age range to the alcoholics. None smoked more than 20 cigarettes/day or admitted taking more than an occasional alcoholic beverage. Prior to study, none had ingested alcohol for at least 72 h or antiplatelet drugs for at least two weeks.
Blood was collected with minimal stasis through a 19-gauge butterfly infusion set using a two-syringe technique and discarding the first 5 ml. Samples were collected on the day of admission (day 1) on days 3 or 4 and 7 or 8 and then at weekly intervals for at least three weeks thereafter. Liver function tests, blood alcohol estimation, platelet count, platelet aggregation studies and platelet adenine nucleotide assays were performed as previously described. PLATELET STUDIES Results are shown in the Figure. None of the subjects was thrombocytopenic on admission, but all except two (whose initial counts were high) showed a rise in platelet count which peaked at two weeks and which was significantly raised for the group as a whole at weeks 2 (p = 0-001) and 3 (p = 0 025).
Platelet aggregability was invariably depressed on admission. The most striking change was the absence of secondary aggregation, although in some cases the primary wave was also reduced. The defect was maximal with adenosine diphosphate (ADP) and adrenaline as agonists but in many cases was also observed with collagen and ristocetin. During the first week after alcohol withdrawal, platelet aggregability was variable. In those whose defect was most marked on admission, improved responses were usually seen. In milder cases, platelet function often decreased initially. However, by seven to 14 days after withdrawal, compared to controls, all subjects had hyperaggregable platelets and again, this was most obvious with ADP and adrenaline where it reached statistical significance (p = 0-01). Over close to zero and significantly (p = 0 002) lower than in controls. During alcohol withdrawal, a significant increase occurred and the mean level exceeded the normal range (15%) (p = 0-001) at weeks 2 and 3.
Slightly low concentrations of ATP and ADP were observed in a few patients initially. Values rose steadily over three weeks at which point the total content was significantly (p = 0-01) above baseline. Mean results for total nucleotides and ATP:ADP ratio were within the normal range throughout.
Discussion
We have demonstrated significant increases in a number of accepted laboratory markers of in vivo platelet activation in a group of heavy drinkers during alcohol withdrawal. On admission all subjects were alcoholaemic and showed decreased platelet aggregability, but within a few days of commencing withdrawal, increases in platelet count, platelet aggregability, circulating platelet aggregates and /3 TG concentrations occurred in all subjects. These values peaked significantly above the normal range but had returned to the reference range by four weeks.
Platelet hyperaggregability, increase of circulating platelet aggregates or (3 TG concentrations are found in myocardial infarction,'3 transient ischaemic attacks'3 and in conditions such as diabetes mellitus'4 in which an increased risk of thrombosis occurs. The reason why the alcoholics in the present study did not show clinical evidence of thromboembolism could relate to the absence of additional risk factors such as dehydration, congestive cardiac failure or cardiac arrhythmia. Alternatively, subclinical thrombosis may have occurred. The cerebral microcirculation is a possible site for this increased thrombotic activity, as previous studies have shown that cerebral blood flow is reduced by 30% during alcohol withdrawal. '1 In contrast to the present study, previous workers have reported deep vein thrombosis and pulmonary embolus in 4/7 alcoholics after admission to hospital, and suggested that these complications were associated with "rebound thrombocytosis" observed seven days after cessation of drinking.3 Nonalcoholics recovering from an alcoholic binge also appear to be at risk from thrombosis, with a recent study of cerebrovascular accidents in patients under the age of 40 yr, showing that in 15% of cases, illness was preceded by excess alcohol consumption.'6 A high incidence of pulmonary embolus occurs in association with alcoholic cardiomyopathy'" and a significant proportion of normotensive men under the age of 50 yr presenting with cerebral thrombosis have been shown to be heavy drinkers.2 However, neither of these latter two studies specify whether the thromboembolic episode coincided with drinking or abstinence.
The aetiology of the platelet changes is uncertain. With regard to our finding of platelet hypoaggregability during alcoholaemia, this is previously described6 and may be relevant to the observation that moderate levels of alcohol consumption is associated with protection from acute myocardial infarction.20 Unfortunately with larger dosage, cardiovascular mortality increases but it is unknown whether death occurs during alcohol consumption or during withdrawal. If the latter is shown to be the case, then the findings of the present study will prove to be of considerable clinical importance.
